AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection
Biomedical Microdevices · 2025
DOI: 10.1007/s10544-025-00775-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Microdevices, 2025. Verfasst von Ulviye Ki̇li̇mci̇ und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Department of Chemistry, Aydın Adnan Menderes University, Aydın, Turkey. Hauptthemen laut MEDLINE: Carcinoembryonic Antigen, Gold, Metal Nanoparticles, Biosensing Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
In this study, a novel immunosensor for carcinoembryonic antigen (CEA) determination was designed, and the synergistic effect of zero-dimensional gold nanoparticles and two-dimensional nanomaterials TiS2 was investigated. In this regard, gold nanoparticles were electrochemically deposited on the surface of the screen-printed electrode (SPE), with MAU employed as a surface activation agent following the insertion of TiS2 nanosheets. The anti-CEA was attached to the surface through EDC/NHS chemistry, utilizing the carboxy end of MUA attached to AuNPs and TiS2 nanosheets. The resulting structure was subsequently protected by Nafion, and non-specific binding to the surface was prevented by the addition of bovine serum albumin (BSA). In a similar manner, an immunosensor was formulated that did not contain TiS₂. CEA quantification was executed via an impedimetric approach. A comprehensive evaluation of the impedimetric outcomes indicated that the immunosensor comprising AuNPs alone was inadequate in achieving an accurate measurement range. Nevertheless, an immunosensor with a very low concentration range (1-100 pg/mL) and a low limit of detection (LOD, 0.21 pg/mL) value could be prepared through the synergistic effect of TiS2. The AuNPs-TiS2-based immunosensor exhibits both high selectivity and reproducibility. Furthermore, the immunosensor exhibits noteworthy storage stability, thus making it well-suited for the quantification of CEA in biological specimens, such as blood. The properties described herein serve to substantiate the hypothesis that the Au-TiS2-based immunosensor is a promising candidate for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Science, Department of Chemistry, Aydın Adnan Menderes University, Aydın, Turkey.
- Faculty of Medicine, Girne American University, Kyrenia, Cyprus.
- Nanotechnology Application, and Research Center, Aydın Adnan Menderes University, Aydın, Turkey.
- Faculty of Science, Department of Chemistry, Aydın Adnan Menderes University, Aydın, Turkey. daktasuygun@gmail.com.
- Nanotechnology Application, and Research Center, Aydın Adnan Menderes University, Aydın, Turkey. daktasuygun@gmail.com.
Zitieren
APA
Ki̇li̇mci̇, U., Öndeş, B., Şahi̇n, Y., Uygun, M., & Uygun, D. A. (2025). AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection. Biomedical Microdevices. https://doi.org/10.1007/s10544-025-00775-w
Vancouver
Ki̇li̇mci̇ U, Öndeş B, Şahi̇n Y, Uygun M, Uygun DA. AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection. Biomedical Microdevices. 2025. doi:10.1007/s10544-025-00775-w
BibTeX
@article{Kilimci2025,
author = {Ki̇li̇mci̇, Ulviye and Öndeş, Baha and Şahi̇n, Yüksel and Uygun, Murat and Uygun, Deniz Aktaş},
title = {AuNPs-TiS2 modified label-free ultrasensitive electrochemical immunosensor for carcinoembryonic antigen (CEA) detection},
journal = {Biomedical Microdevices},
year = {2025},
doi = {10.1007/s10544-025-00775-w}
}
EUVIMED